Mycobacteria in Organ Transplant Recipients

Area of Science:

• Infectious Diseases
• Transplantation Medicine
• Public Health

Background:

• Solid organ transplant (SOT) recipients are a vulnerable population for infections.
• Tuberculosis (TB) poses a significant risk in SOT recipients due to immunosuppression.
• Other difficult-to-treat mycobacteria, like Mycobacterium abscessus and Mycobacterium avium complex, also present challenges.

Purpose of the Study:

• To review the epidemiology and risk factors of TB in SOT recipients.
• To outline strategies for pre-transplant TB screening and latent TB management.
• To discuss the complexities of managing TB and other mycobacterial infections in this cohort.

Main Methods:

• Literature review focusing on epidemiological data and clinical management guidelines.
• Analysis of risk factors associated with TB development post-transplantation.
• Examination of treatment challenges and drug interactions.

Main Results:

• Identification of key risk factors for TB in SOT recipients.
• Emphasis on the importance of pre-transplant screening and latent TB treatment.
• Highlighting the challenges in managing disseminated TB and non-tuberculous mycobacteria.
• Noting significant drug interactions between rifamycins and immunosuppressants.

Conclusions:

• Proactive screening and management of TB are essential for SOT recipients.
• Careful monitoring is required due to potential drug interactions with immunosuppressive therapy.
• Addressing TB and other mycobacterial infections requires a tailored approach in transplant patients.